Krishnan Viswanadhan - 05 Mar 2025 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Chief Corp Dev & Strategy
Signature
/s/ William Cook, as Attorney in Fact for Krishnan Viswanadhan
Issuer symbol
AGIO
Transactions as of
05 Mar 2025
Net transactions value
$0
Form type
4
Filing time
07 Mar 2025, 16:18:52 UTC
Previous filing
06 Jun 2024
Next filing
23 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Restricted stock units Award $0 +24,300 $0.000000 24,300 05 Mar 2025 Common stock 24,300 Direct F1, F2
transaction AGIO Stock options (right to buy) Award $0 +55,374 $0.000000 55,374 05 Mar 2025 Common stock 55,374 $33.95 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2 The restricted stock units were granted on March 5, 2025. Beginning on March 5, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
F3 This option was granted on March 5, 2025. The shares underlying this option vest as to 25% of the underlying shares on March 5, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter.